Anti-CDK20 Antibody

CDK20 (Cyclin-Dependent Kinase 20), also referred to as CCRK, is a serine/threonine kinase involved in cell cycle progression, primary cilium assembly, and Wnt/β-catenin signaling, with elevated expression reported in hepatocellular carcinoma, glioblastoma, and ovarian cancer. This polyclonal reagent from Antibodies.com targets the CDK20 protein for western blot and immunohistochemistry applications. The unconjugated antibody is supplied as a 100 µl volume and is reactive with human, mouse, and rat samples, supporting cross-species studies in tumor biology, developmental signaling, and kinase research.

The polyclonal format offers broad epitope recognition across different tissue contexts, which is useful when probing CDK20 under varied experimental conditions. Researchers studying androgen receptor signaling, cilia-related disorders, or Wnt pathway dysregulation can use this reagent to assess endogenous CDK20 levels by western blot analysis of cell lysates or by immunohistochemistry on fixed tissue sections. To preserve activity, aliquot upon arrival and limit freeze-thaw cycles across repeated experiments.